BAUSSS biomarker further validated as a key risk staging tool for patients with primary melanoma.
Dixon AJ, Kyrgidis A, Sladden M, Nirenberg A, Steinman HK, Smith H, Zachary CB, Anderson S, Leiter-Stöppke U, Longo C, Apalla Z.
Dixon AJ, et al. Among authors: sladden m.
J Eur Acad Dermatol Venereol. 2024 Sep;38(9):e779-e781. doi: 10.1111/jdv.19889. Epub 2024 Feb 20.
J Eur Acad Dermatol Venereol. 2024.
PMID: 38375764
No abstract available.